Search Results 111-120 of 15431 for infliximab

  1. Postoperative Infections Clinical Trials - Mayo Clinic Research

    ... infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side ...

  2. Etanercept-ykro (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Cholera Vaccine, Live; Cyclophosphamide; Dengue Tetravalent Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live ...

  3. https://www.mayoclinic.org/patient_consumer_drug.xml

    ... infliximab-axxq-intravenous-route/description/drg-20476981</loc><lastmod>2025-02-01T00:00:00-06:00</lastmod></url><url><loc>https://www.mayoclinic.org/drugs ...

  4. Researchers FISH for Answers about Barrett's Esophagus

    Study Shows Crohn's Disease Patients Benefit From Infliximab Plus Azathioprine · Study Suggests Improved DNA Stool Test Could Detect Digestive Cancers in ...

  5. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

    Has not previously received an approved biologic for CD (i.e., infliximab, adalimumab, certolizumab pegol, ustekinumab, natalizumab, vedolizumab or approved ...

  6. Clinical Trials - TD-1473 for Active Ulcerative Colitis (UC)

    ... infliximab, golimumab, etanercept, or certolizumab within the 60 days prior to Day 1, c) intravenous corticosteroids within the 14 days prior to Day 1, d ...

  7. Aminophylline (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab; Isoniazid; Ketamine. Show More. Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but ...

  8. Etanercept-szzs (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Cholera Vaccine, Live; Cyclophosphamide; Dengue Tetravalent Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live ...

  9. A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    Infliximab, certolizumab, golimumab, ABA or adalimumab within ≤ 8 weeks; Anakinra within ≤ 1 week. Pulmonary disease with FVC ≤ 50% of predicted, or DLCO ...

  10. Publications - C. Scott Collins, M.D. - Mayo Clinic

    ... infliximab. BMJ Case Rep. 2013 Mar 15; 2013. View PubMed; Feely MA, Collins CS, Daniels PR, Kebede EB, Jatoi A, Mauck KF. Preoperative testing before ...